These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3280329)

  • 1. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release.
    Snell LD; Yi SJ; Johnson KM
    Eur J Pharmacol; 1988 Jan; 145(2):223-6. PubMed ID: 3280329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801.
    Lalies M; Middlemiss DN; Ransom R
    Neurosci Lett; 1988 Sep; 91(3):339-42. PubMed ID: 2847087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801.
    Schmidt CJ; Taylor VL
    Eur J Pharmacol; 1988 Oct; 156(1):111-20. PubMed ID: 2850205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
    Jones SM; Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release by phencyclidine is dependent on potassium concentration.
    Snell LD; Jones SM; Johnson KM
    Neurosci Lett; 1987 Aug; 78(3):333-7. PubMed ID: 2888064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
    Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
    Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage between phencyclidine (PCP) and N-methyl-D-aspartate (NMDA) receptors in the cerebellum.
    Yi SJ; Snell LD; Johnson KM
    Brain Res; 1988 Mar; 445(1):147-51. PubMed ID: 2835121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain.
    Silverstein FS; McDonald JW; Bommarito M; Johnston MV
    Stroke; 1990 Feb; 21(2):310-5. PubMed ID: 1968295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons.
    Drejer J; Honoré T
    Eur J Pharmacol; 1987 Nov; 143(2):287-90. PubMed ID: 3319651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.
    Davies SN; Martin D; Millar JD; Aram JA; Church J; Lodge D
    Eur J Pharmacol; 1988 Jan; 145(2):141-51. PubMed ID: 2832187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC
    Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison.
    Grigg JJ; Anderson EG
    J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of agonists and noncompetitive antagonists at the excitatory amino acid receptors in rat retinal ganglion cells in vitro.
    Karschin A; Aizenman E; Lipton SA
    J Neurosci; 1988 Aug; 8(8):2895-906. PubMed ID: 2842467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
    Sanger DJ; Jackson A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.